We are live on ! Find out more
TCRX icon

TScan Therapeutics
TCRX

27 hedge funds and large institutions have $83.5M invested in TScan Therapeutics in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53.91% more ownership

Funds ownership: 0% → 53.91% (+54%)

Holders
27
Holders Change
+27
Holders Change %
–
% of All Funds
0.47%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
27
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.9M
2
BBA
Baker Bros. Advisors
New York
+$13.2M
3
HA
HHLR Advisors
Cayman Islands
+$11.9M
4
RCM
RA Capital Management
Massachusetts
+$11.6M
5
DIC
Deer IX & Co
New York
+$11.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$12.5M +$13.9M +1,500,577 New
BBA
2
Baker Bros. Advisors
New York
$11.9M +$13.2M +1,425,000 New
HA
3
HHLR Advisors
Cayman Islands
$10.7M +$11.9M +1,282,976 New
RCM
4
RA Capital Management
Massachusetts
$10.5M +$11.6M +1,255,317 New
DIC
5
Deer IX & Co
New York
$9.35M +$11.6M +1,245,505 New
AI
6
Alphabet Inc
California
$8.98M +$9.99M +1,077,080 New
DF
7
DC Funds
Virginia
$5.25M +$5.84M +630,000 New
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$4.14M +$4.61M +496,583 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$3.71M +$4.13M +444,894 New
TCM
10
Tekla Capital Management
Massachusetts
$1.67M +$1.85M +200,000 New
Wellington Management Group
11
Wellington Management Group
Massachusetts
$1.16M +$1.29M +139,566 New
MIM
12
Monashee Investment Management
Massachusetts
$834K +$927K +100,000 New
CCM
13
CAAS Capital Management
New York
$626K +$696K +75,000 New
Norges Bank
14
Norges Bank
Norway
$500K +$556K +60,000 New
DIM
15
DC Investments Management
Virginia
$297K +$330K +35,563 New
Millennium Management
16
Millennium Management
New York
$252K +$280K +30,240 New
Morgan Stanley
17
Morgan Stanley
New York
$235K +$262K +28,236 New
Two Sigma Investments
18
Two Sigma Investments
New York
$190K +$212K +22,817 New
SSA
19
Schonfeld Strategic Advisors
New York
$185K +$206K +22,200 New
Two Sigma Advisers
20
Two Sigma Advisers
New York
$108K +$121K +13,000 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$106K +$119K +12,786 New
State Street
22
State Street
Massachusetts
$102K +$113K +12,200 New
Citadel Advisors
23
Citadel Advisors
Florida
$99K +$111K +11,922 New
Goldman Sachs
24
Goldman Sachs
New York
$96K +$107K +11,531 New
UBS Group
25
UBS Group
Switzerland
$8K +$8.77K +946 New
1
2

TCRX Hedge Fund Activity: Q3 2021 in Review

27 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in TScan Therapeutics (TCRX) for Q3 2021, worth a combined $83.5M.

Buyers outnumbered sellers: 27 funds opened new TCRX positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $13.9M.

  • 27 institutional investors held TScan Therapeutics (TCRX) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $83.5M of TScan Therapeutics stock for Q3 2021.
  • 27 funds opened new TScan Therapeutics positions in Q3 2021 and 0 closed out, a net change of +27 holders.
  • The largest TScan Therapeutics buyer in Q3 2021 was BlackRock, an estimated $13.9M added.

Based on aggregated 13F filings for Q3 2021.